Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
A guide to using dithranol
Neil H Cox
In a discipline that some view as a Cinderella specialty, dithranol is probably the Cinderella treatment. Competition with newer, cleaner treatments creates a danger that dithranol could fall by the wayside even though, when used properly, it can be highly effective. Dithranol (‘anthralin’ in the USA, ‘cignolin’ in parts of Europe) is one of the oldest treatments for psoriasis, with numerous poorly understood effects on DNA production and mitotic rate, cyclic nucleosides, arachidonic acid and glycolytic enzymes in the skin.
Dermatology in practice
2006;
14
(4): 18–22
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
Phase 3 trial results announced for melanoma treatment
Global atopic dermatitis awareness campaign launched
Promising results from phase 2 skin cancer trial
Dermavant’s Vtama shows promise in paediatric atopic dermatitis trial
Almirall’s lebrikizumab approved by EMA for atopic dermatitis
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy